Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Mangalam Drugs and Organics Ltd.

  • NSE: MANGALAM

  • BSE: 532637

  • Q
  • V
  • T
  • Strong Performer
56.75/100

Quality Score

High Financial Strength
53.50/100

Valuation Score

Affordable Valuation
68.59/100

Technical Score

Technically Moderately Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

37.35

MFI is mid-range

50Day SMA Rs

70.38 Rs

Price below SMA-50

Quality score

56.75

High Financial Strength

30Day SMA Rs

66.17 Rs

price crossed below SMA30 today

Broker Covering stock

1.00

1 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Momentum score

68.59

Technically Moderately Bullish

Price to Book Value

1.07

Below industry median.

Broker Reports in 1Yr

1.00

1 Broker Reports in 1Yr

PE TTM Price to Earnings

12.47

Below industry median.

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

47.88

RSI is mid-range

Net Profit Qtr Cr

5.05 Cr

Above industry median.

Operating Revenues Qtr Cr

88.09 Cr

Above industry median.

MACD

0.64

MACD above Center

Valuation score

53.50

Affordable Valuation

MACD Signal Line

1.29

MACD above Center

FII holding holding %

0.16 %

FII holding increased by 0.16%.

Promoter holding holding %

50.53 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

51.86 Rs

Price above SMA 51.86

Institutions holding holding %

0.01 %

Institutions holding decreased by 0.07%.

200Day SMA Rs

41.11 Rs

Price above SMA 41.11

NSE MANGALAM
0.00
  • 0.00 Close
  • 0.00 Open
  • 0.00 Volume
Today Low/High
Low 0.00
High 0.00
52 Week Low/High
0.00
0.00

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Mangalam Drugs and Organics Ltd. 65 12.46 102.88 0 5.05 202.75 88.09 83.19 1.07
Sun Pharmaceutical Industries Ltd. 494.7 28.34 118693.37 1.16 494.35 30.45 8184.94 14.25 2.65
Dr. Reddy's Laboratories Ltd. 3922 33.08 65183.64 0.5 770.6 3.34 4448.89 10.4 4.64
Divi's Laboratories Ltd. 2200.6 42.43 58414.92 1.45 388.23 1.75 1389.71 9.67 8.39
Cipla Ltd. 641.29 33.42 51704.81 1.09 242.31 2.47 4376.18 -0.64 3.36
Aurobindo Pharma Ltd. 820.3 16.89 48061.37 0.36 868.3 20.44 6158.43 16.36 3.45
Torrent Pharmaceuticals Ltd. 2394.35 39.53 40521.97 1.33 314 134.92 1946 4.84 8.53
Lupin Ltd. 865.15 -143.19 39191.29 0.57 390.3 -144.75 3845.74 -12.73 2.83